Attempts to model AML from proto-oncogenes KRASG12D [20], NUP98-HOXA9 [21] and AML1-ETO [22] have instead led to new models of myeloproliferative neoplasms (MPN) that for unknown reasons do not advance to AML. Here, RUNX1 is linked to myeloproliferative disorder.